AUTOTAC Bio
- Biotech or pharma, therapeutic R&D
AUTOTAC Bio challenges to create the new modality for target protein degradation platform technology using AUTOTAC(Autophagy-Targeting Chimera). With AUTOTAC platform, we are developing first-in-class therapeutics targeting CNS diseases such as AD and PD.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}